Therapy Areas: Oncology
Akrevia Therapeutics names new Chief Operating Officer
13 June 2019 -

Akrevia Therapeutics, a privately-held biopharmaceutical company focused on developing highly-potent, tumour-targeted immuno-oncology therapeutics, announced yesterday that it has named Joseph Farmer as its new Chief Operating Officer.

Farmer will lead Akrevia's business development, finance, administrative, and business operations functions. He will report to Rene Russo, PharmD, Akrevia's Chief Executive Officer.

Farmer is a biopharma executive with more than 20 years of industry experience. Prior to joining Akrevia, he most recently served as Senior Vice President, General Counsel, and Corporate Secretary at Tesaro, Inc. Prior to Tesaro, he was Chief Corporate Counsel and Assistant Secretary at Cubist Pharmaceuticals Inc.



Related Headlines